K. Clinton Cary, MD, MPH

Dr. Clint Cary’s research efforts focus on improving the health of patients with urologic cancers through health services and outcomes research in testis, bladder, and prostate cancer. He has a study in progress to assess utilization rates of single dose intravesical chemotherapy in patients with non-muscle invasive bladder cancer in a population-based environment.

He actively publishes on advanced testicular cancer outcomes in numerous high-impact journals and has authored numerous book chapters on the topic of testicular cancer. He has served as a Visiting Professor both nationally and internationally to disseminate his research findings.

He provides direct medical and surgical care, with a specific focus on patients with testicular cancer and bladder cancer.

Dr. Cary serves as the Director of Urologic Oncology Research for the Department of Urology, a member of the American Urological Association (AUA) Young Urologists Committee, and AUA Liaison to the Young Physician Section of AMA House of Delegates.